首页> 外文期刊>Clinical oral implants research >Biological and technical outcomes of restored implants after maxillary sinus augmentation— Results at 1‐year loading Results at 1‐year loading
【24h】

Biological and technical outcomes of restored implants after maxillary sinus augmentation— Results at 1‐year loading Results at 1‐year loading

机译:上颌窦增强后恢复植入物的生物学和技术结果 - 结果在1年载量的1年载结果下

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Objective To report biological and technical outcomes of implant‐supported restorations placed into previously maxillary sinus floor augmentation using the lateral wall approach (MSA) using anorganic bovine bone mineral (ABBM)?+?autogenous bone (AB) (control group) or collagen‐stabilized ABBM (test group). Materials and methods Single implant was placed 6?months after MSA in 27 control and 26 test patients. Fixed restorations were delivered 12?weeks later and reviewed 12?months after function. Outcomes measured included implant survival, marginal bone levels (DIB), peri‐implant parameters, and incidence of biological and technical complications. Results Seven patients (three control, four test group) did not return for their 1‐year review. No significant inter‐group differences were noted for all parameters. At baseline (3?months after implant placement), a mean( SD ) marginal bone loss of 0.66?mm (0.40) and 0.77?mm (0.48) from the implant shoulder was recorded in the control and test group, respectively. After 12?months of loading, a mean ( SD ) additional marginal bone loss of 0.32?mm (0.24) and 0.35?mm (0.23) was noted in the control and test group, respectively. Peri‐implant mucositis (≥1 site BOP) was diagnosed in 62.9% of control and 69.23% of test patients. No peri‐implantitis was diagnosed. Screw retention and single crowns predominated. Technical complications mostly comprised of ceramic veneer chipping and were noted in 7.4% of control and 11.54% of test patients. Conclusion Based on a short observation period, implant reconstruction of the partially edentulous posterior maxilla after MSA using ABBM?+?AB or collagen‐stabilized ABBM led stable marginal bone levels, high prevalence of peri‐implant mucositis, and low rates of technical complications.
机译:摘要目的通过使用横壁方法(MSA)使用无机牛骨矿物(ABBM)(ABBM)(ABBM)(对照组)或胶原蛋白(对照组)或胶原蛋白(对照组)或胶原蛋白(对照组)或胶原蛋白(对照组)或胶原蛋白-Abilized ABBM(测试组)。材料和方法单植入物在MSA中置于27个对照和26个测试患者后。固定修复恢复12个星期后,并在职能后12个月审查。测量的结果包括植入物存活,边缘骨水平(​​DIB),PERI-植入参数和生物学和技术并发症的发生率。结果7名患者(三项控制,四项试验组)未返回其1年审查。所有参数都没有注意到重大的组间差异。在对照组和试验组中,在对照组和试验组中记录了从植入物肩部的平均值(SD)边际骨损失为0.66Ωmm(0.40)和0.77Ω(0.48)的平均值(SD)边际骨损失。在12个月的载荷后,在对照和试验组中,分别注意到0.32Ωmm(0.24)和0.35Ωmm(0.23)的平均值(SD)额外的边际骨质损失。 Peri-植入物粘膜炎(≥1位点BOP)被诊断为62.9%的对照和69.23%的测试患者。没有诊断出没有血管炎。螺钉保持和单个冠占主导地位。技术并发症主要由陶瓷贴面切换组成,并以7.4%的对照和11.54%的测试患者指出。结论基于短期观察期,MSA使用ABBM植入部分透明的后颌骨植入物的重建使用ABBMα+α或胶原蛋白稳定的ABBM LED稳定的边际骨水平,肝细胞酸性肌炎的普及率高,技术并发症的低率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号